APA (7th ed.) Citation

Van Laethem, J., Hammel, P., Mornex, F., Azria, D., Van Tienhoven, G., Vergauwe, P., . . . Haustermans, K. (2010). Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: A randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. Journal of clinical oncology, 28(29), 4450. https://doi.org/10.1200/JCO.2010.30.3446

Chicago Style (17th ed.) Citation

Van Laethem, Jean-Luc, et al. "Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study." Journal of Clinical Oncology 28, no. 29 (2010): 4450. https://doi.org/10.1200/JCO.2010.30.3446.

MLA (9th ed.) Citation

Van Laethem, Jean-Luc, et al. "Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study." Journal of Clinical Oncology, vol. 28, no. 29, 2010, p. 4450, https://doi.org/10.1200/JCO.2010.30.3446.